The present invention relates to certain phenyl urea and phenyl carbamate derivatives pharmaceutical compositions containing them and methods of using them including methods for preventing reversing slowing or inhibiting protein aggregation and methods of treating diseases that are associated with protein aggregation including neurodegenerative diseases such as Parkinson s disease Alzheimer s disease Lewy body disease and multiple system atrophy.